ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
4
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,102
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro
Author(s):
LJ Hofland
,
J Sande
,
PM Koetsveld
,
W Herder
,
M Waaijers
,
D. B. de Mooij
Publication date:
2004
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Journal of the ASEAN Federation of Endocrine Societies
Data availability:
ScienceOpen disciplines:
Endocrinology & Diabetes
,
Medicine
Comments
Comment on this article
Sign in to comment
Similar content
3,102
Significant response to pasireotide (SOM230) in the treatment of a patient with persistent, refractory Cushing's disease.
Authors:
Fabian Kurth
,
Kimberly Cukier
,
R. Tewari
…
SOM230 (pasireotide) and temozolomide achieve sustained control of tumour progression and ACTH secretion in pituitary carcinoma with widespread metastases
Authors:
H. Bode
,
M Seiz
,
S. Lammert
…
Transient efficacy of octreotide and pasireotide (SOM230) treatment in GIP-dependent Cushing's syndrome.
Authors:
Livia M Mermejo
,
Andre Lacroix
,
P Damoiseaux
…
See all similar
Cited by
1
Somatostatin receptors subtypes 2 and 5, dopamine receptor type 2 expression and gsp status as predictors of octreotide LAR® responsiveness in acromegaly
Authors:
Leonardo Vieira Neto
,
Giselle Taboada
,
Mônica Gadelha
See all cited by